Effect of highly active antiretroviral therapy on survival in patients with AIDS-associated pulmonary Kaposi's sarcoma treated with chemotherapy.
about
Clinical characteristics, predictors of immune reconstitution inflammatory syndrome and long-term prognosis in patients with Kaposi sarcoma.Molecular biology of KSHV in relation to AIDS-associated oncogenesis.NANOMATERIALS FOR PROTEIN MEDIATED THERAPY AND DELIVERY.Insights into pathogenic events of HIV-associated Kaposi sarcoma and immune reconstitution syndrome related Kaposi sarcoma.KSHV LANA--the master regulator of KSHV latency.Brain localization of Kaposi's sarcoma in a patient treated by combination antiretroviral therapyUse of boosted protease inhibitors reduces Kaposi sarcoma incidence among male veterans with HIV infection.Antitumour effects of antiretroviral therapy.Management of patients with HIV in the intensive care unitDown-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity.Trends in Kaposi's Sarcoma in Miami Beach from 1987 to 2007Incidence, predictors and significance of severe toxicity in patients with human immunodeficiency virus-associated Hodgkin lymphoma.Pulmonary Kaposi sarcoma in AIDSPersistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response.Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma.
P2860
Q33442216-B7501A3C-9679-420C-BF1F-E925D9878DBBQ33560572-D89A148A-7CEE-438F-A55C-03F8564D3FFEQ34534023-A54F3F8C-C391-489A-B504-A2CFD5F71DBDQ34587349-52191A23-C11A-4005-9366-08C553F6934EQ34774797-E410DFF6-D934-4EAA-8E95-4768BB30F60DQ35073605-C5C7280A-47B9-4FE6-A1ED-3F398DB03533Q35715660-4D954C85-F289-47E6-A7DD-9E9557EAEC7CQ35934144-80A5F23A-463F-4858-A97C-79D68C23D9EDQ36403151-4B058269-A6A4-42B5-BD3A-923E14CC9624Q36446460-1FDC869A-79D8-4D5A-B161-57EB94CC1792Q36520006-761DD890-7B2D-4920-A6B5-60E1C03EE89EQ38014151-4E90F4CF-8EBB-4FDC-AB32-428726D1174DQ41187077-2DB0B4FB-65A3-4DF6-9D53-7C9746D16550Q41956982-4A0A13ED-21C8-426F-BBF0-074F7F817135Q46473122-9C5169D8-D864-4080-A64B-ED4E1CF75ACB
P2860
Effect of highly active antiretroviral therapy on survival in patients with AIDS-associated pulmonary Kaposi's sarcoma treated with chemotherapy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Effect of highly active antire ...... oma treated with chemotherapy.
@ast
Effect of highly active antire ...... oma treated with chemotherapy.
@en
Effect of highly active antire ...... oma treated with chemotherapy.
@nl
type
label
Effect of highly active antire ...... oma treated with chemotherapy.
@ast
Effect of highly active antire ...... oma treated with chemotherapy.
@en
Effect of highly active antire ...... oma treated with chemotherapy.
@nl
prefLabel
Effect of highly active antire ...... oma treated with chemotherapy.
@ast
Effect of highly active antire ...... oma treated with chemotherapy.
@en
Effect of highly active antire ...... oma treated with chemotherapy.
@nl
P2093
P1476
Effect of highly active antire ...... oma treated with chemotherapy.
@en
P2093
A Chanan-Khan
C Wasserheit
K Takeshita
R Demopoulos
P304
P356
10.1200/JCO.2001.19.18.3848
P407
P577
2001-09-01T00:00:00Z